Image

Comparing Use of Radiographs Versus Patient Empowerment (CURVE)

Comparing Use of Radiographs Versus Patient Empowerment (CURVE)

Recruiting
10-18 years
All
Phase N/A

Powered by AI

Overview

Objective: To evaluate the (cost-)effectiveness of a new patient-empowered follow up (FU) protocol in patients with Adolescent idiopathic Scoliosis (AIS) that is based on patient-reported outcome measures (PROMs), self-assessment tools and physical examination, which is compared to standard FU care by: 1) Effect evaluation, 2) Economic evaluation, 3) Implementation (process) evaluation.

Study design: A multicentre pragmatic randomized trial design with two arms, combined with a patient preference cohort for each arm (partially randomized preference trial [PRPT]).

Study population: A total of 812 AIS patients (age 10-18 years) treated by the Dutch AIS Consortium, representing the scoliosis treatment centres in the Netherlands, will be included.

Three subgroups of AIS patients are distinguished, which are monitored over two years:

  1. Pre-treatment group: adolescents with curve 10-25° (n=132 per arm; total n=264)
  2. Post-brace treatment group (n=122 per arm; total n=244)
  3. Post-surgery group (n=152 per arm; total n=304)

Intervention: The new patient-empowered FU protocol (PE-FU) is based on PROMs, self-assessment tools and clinical assessment including physical examination. The protocol aims to detect curve progression or postoperative complications based on these patient-based and clinical parameters to substitute the need to obtain routine x-rays. X-rays will only be taken when progression or postoperative complications are suspected in the pre- and post-intervention groups based on predefined criteria. The standard FU protocol consists of routine full-spine radiographs and routine clinical evaluations.

Eligibility

Inclusion Criteria:

  • Patients with adolescent idiopathic scoliosis (AIS).
  • Age: 10-18 years old.
  • Patients scheduled for follow up in one of the participating centres.
  • Understanding of the Dutch language.
  • Signed informed consent.
  • Biplanar (Posterior-Anterior [PA] and Lateral) full-spine x-rays within the last 3 months.

Specifically for the pre-treatment group:

  • Girls aged ≤14 years (i.e. 10-14 years) and boys <16 years (i.e. 10-15 years). These patients still have generally 2 years of remaining skeletal growth. Patients above this age with a curve below 25 degrees have a limited risk for progression
  • Girls: pre-menarche up to 6 months post-menarche (to estimate end of growth)
  • A primary coronal curve of 10-25 degree.

Specifically for the post-brace group:

  • Patients aged 12-18 years
  • Within 3 months after termination of brace treatment
  • Minimum of 6 months of brace treatment

Specifically for the post-surgery group:

• Patients aged 12-18 years

Exclusion Criteria:

  • Patients with juvenile or infantile idiopathic scoliosis with the diagnosis of onset under the age of 10.
  • Patients who are undergoing brace treatment. These patients are not included because of the need to monitor brace therapy with radiographs.
  • Patients who have undergone previous spinal surgery and are undergoing revision surgery.
  • Skeletally mature patients.

Study details
    Adolescent Idiopathic Scoliosis

NCT05379127

Radboud University Medical Center

27 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.